MedTrace Logo

Demographic, Metabolic, and Genomic Description of Neonates With Severe Hyperbilirubinemia

NCT00383318 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2008-01-28

No results posted yet for this study

Summary

The purpose of this study is to compare the demographic, metabolic, and genomic characteristics of patients who develop severe hyperbilirubinemia to patients who never developed a significant bilirubin level.

Conditions

  • Hyperbilirubinemia
  • Jaundice

Interventions

PROCEDURE

Gene mutation sample

Sponsors & Collaborators

  • Pediatrix

    lead OTHER

Principal Investigators

  • Reese H Clark, MD · Pediatrix

  • Zhili Lin, PhD, MD · Pediatrix Screening

  • Jon Watchko, MD · University of Pittsburgh

Eligibility

Max Age
6 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2007-12-31
Completion
2007-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00383318 on ClinicalTrials.gov